Michael A. Dyer, MD

Assistant Professor, Radiation Oncology

Michael Dyer
617.638.7070
830 Harrison Avenue

Biography

Michael Dyer, MD is an Assistant Professor of Radiation Oncology at the Boston University School of Medicine. Previously, he worked as the Resident Coordinator for Medical Student Rotations at Massachusetts General Hospital. Dr. Dyer is also an Ad Hoc Reviewer for the International Journal of Radiation Oncology and a member of the Massachusetts Medical Society, and the American Medical Association. He is a member-in-training of the American Society for Radiation Oncology and the American Society of Clinical Oncology.

Education

  • Harvard Medical School, MD
  • Brown University, AB

Publications

  • Published on 5/9/2018

    Burger EA, Dyer MA, Sy S, Palefsky JM, De Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ. Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. J Acquir Immune Defic Syndr. 2018 May 09. PMID: 29757775.

    Read at: PubMed
  • Published on 1/1/2016

    Dyer, M. A., Chen, M., Braccioforte, M. H., Moran, B. J., D’Amico, A. V. Journal of Radiation Oncology. Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable-risk prostate cancer. Springer Publishing. New York. 2016.

  • Published on 12/15/2015

    Schoenfeld JD, Mahadevan A, Floyd SR, Dyer MA, Catalano PJ, Alexander BM, McDermott DF, Kaplan ID. Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review. J Immunother Cancer. 2015; 3:50. PMID: 26672895.

    Read at: PubMed
  • Published on 6/22/2014

    Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, Hodi FS, Ibrahim N, Weiss SE, Kelly PJ, Floyd SR, Mahadevan A, Alexander BM. The role of whole brain radiation therapy in the management of melanoma brain metastases. Radiat Oncol. 2014 Jun 22; 9:143. PMID: 24954062.

    Read at: PubMed
  • Published on 1/1/2013

    Cather C, Dyer MA, Burrell HA, Hoeppner B, Goff DC, Evins AE. An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia. J Dual Diagn. 2013; 9(1):87-93. PMID: 23750123.

    Read at: PubMed
  • Published on 7/15/2012

    Dyer MA, Kelly PJ, Chen YH, Pinnell NE, Claus EB, Lee EQ, Weiss SE, Arvold ND, Lin NU, Alexander BM. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e479-86. PMID: 22704705.

    Read at: PubMed
  • Published on 1/25/2010

    Qureshi A, Nan H, Dyer M, Han J. Polymorphisms of FAS and FAS ligand genes and risk of skin cancer. J Dermatol Sci. 2010 Apr; 58(1):78-80. PMID: 20219325.

    Read at: PubMed
  • Published on 1/1/2009

    Dyer, M. A., Lieberman, G. Etiology and diagnosis of intracranial hypertension: Using MRI to narrow an index patient’s differential. Harvard University. Cambridge. 2009.

    Read at: Custom
  • Published on 3/5/2008

    Dyer MA, Freudenreich O, Culhane MA, Pachas GN, Deckersbach T, Murphy E, Goff DC, Evins AE. High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. Schizophr Res. 2008 Jul; 102(1-3):88-95. PMID: 18325740.

    Read at: PubMed
  • Published on 4/18/2007

    Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008 Feb; 33(3):480-90. PMID: 17443126.

    Read at: PubMed

View 1 more publications: View full profile at BUMC

View all profiles